Search (News)

Medicus Pharma To Present New Teverelix Data At AACE 2026 Demonstrating Long-Acting Hormone Suppression

health top

(MENAFN - GlobeNewsWire - Nasdaq) Updated Safety, Efficacy, and Clinical Data Supports Teverelix as Potentially the First Long-Acting Injectable GnRH Antagonist Across Multiple Indications in ...
2026-04-15 07:32:29